This week’s Alpha Trader podcast features hosts Aaron Task and Stephen Alpher talking with George Ball, chairman of Sanders, Morris, Harris.
Among the topics discussed:
Stocks are expensive and the bull market is long in the tooth, but the Fed (or at least Chairman Jay Powell) is showing little interest in tightening policy. While fast growth and perky inflation would seemingly argue for the Fed to move, don’t discount that Powell would like to keep his job - tapering and/or higher rates wouldn’t be the best career move.
What might upset this equation is the Fed having gotten it wrong on “transitory” inflation. Last week’s “soft” employment report was notable for a 0.6% rise in average hourly earnings - double what was expected. While one could argue that the taper is priced into stock prices, Ball says higher and stickier than expected wage-led inflation certainly isn’t.
Nevertheless remaining bullish, Ball prefers “new tech” names that have far greater upside than the FAANG+ players. Among them are MercadoLibre (MELI) and Chegg (CHGG) - both stocks have had astounding gains over the past few years, but the best way to invest, says Ball, is to have the memory span of a goldfish. The market caps of each remain relatively small compared to the market opportunities they have.
Bullish on cryptocurrencies, Ball recommends splitting an investment up three ways - one-third in bitcoin (BTC-USD), one-third in ether (ETH-USD), and one-third in Coinbase (COIN). If worried about the competitive threat that Coinbase may face as other exchanges raise funds in IPOs, Ball wouldn’t have issue buying a basket of these players instead of just Coinbase.
Ball is also a fan of a recently gone-public small-cap biotech, Sera Prognostics (SERA). The company has a test which can determine if a woman is likely to give birth to a baby prematurely. By being able to identify and treat this condition early, the savings - both from a human and cost standpoint - would be enormous.
Learn more about your ad choices. Visit megaphone.fm/adchoices